uniQure (QURE) Stock Price, Quote, News & History | Benzinga

uniQure NV (QURE) Stock Price, Quote, News & History

QURENASDAQ

Trade with Public

Trade with Public

$48.36

-0.68-1.39%

Last update: Jun 24, 10:13 AM

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$49.80

Close

-

Volume / Avg.

1.66M / 2.05M

Day Range

$47.02 - $50.05

52 Wk Range

8.73 - 71.50

Market Cap

$3.05B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

17.86%

Days to Cover

9.04

Recent Uniqure NV News

uniQure's Experimental Drug Shows Early Promise In Difficult-To-Treat Epilepsy

uniQure reported early seizure reductions in an AMT-260 epilepsy study, with no treatment-related serious adverse events.

Vandana Singh

Regenxbio Gains Fresh Chance As FDA Reconsiders Gene Therapy

FDA reverses its rejection of Regenxbio Navsunli, allowing the company to refile its gene therapy application.

Vandana Singh

uniQure Soars After FDA's U-Turn Opens Accelerated Approval Pathway for Huntington's Therapy

Timur Mekhantev

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-172.11M

Investing Cash Flow (TTM)

-243.16M

Financing Cash Flow (TTM)

335.28M

Free Cash Flow (TTM)

-172.56M

Capital Expenditure (TTM)

-453.00K

Net Change in Cash (TTM)

-79.99M

Analyst Trends and Forecast

7

5

Mar

1

1

Apr

1

May

3

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.57B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

162.38

PB Ratio (TTM)

20.71

Earnings Yield % (TTM)

-7.12%

Earnings Yield % (FWD)

-6.83%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.37

Company Debt

Total Debt

$49.94M

LT Debt

$49.94M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$139.99M

Debt to Equity

0.42

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$49.80

Close

-

Volume / Avg.

1.66M / 2.05M

Day Range

$47.02 - $50.05

52 Wk Range

8.73 - 71.50

Market Cap

$3.05B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

17.86%

Days to Cover

9.04

About

Sector

Health Care

Industry

Biotechnology

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy uniQure (QURE) stock?

A

You can purchase shares of uniQure (NASDAQ:QURE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are uniQure (QURE) competitors?

A

There are no as such competitors for uniQure.

Q

What is the forecast, or price target, for uniQure (QURE) stock?

A

uniQure has a consensus price target of $52.71.

Q

What is the current price for uniQure (QURE)?

A

The stock price for uniQure (NASDAQ: QURE) is $48.36 last updated June 24, 2026 at 10:13 AM EDT.

Q

Does uniQure (QURE) pay a dividend?

A

There are no upcoming dividends for uniQure.

Q

When is uniQure (NASDAQ:QURE) reporting earnings?

A

uniQure does not have any upcoming earnings scheduled.

Q

Is uniQure (QURE) going to split?

A

There is no upcoming split for uniQure.

Q

What sector and industry does uniQure (QURE) operate in?

A

uniQure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.